MERGER UPDATE: BFA Law is Investigating Whether the $45 Per Share Offer for Cerevel Is Too Low and Reminds Shareholders to Contact the Firm
![Accesswire](../../../Content/images/providers/AW.png)
Cerevel Therapeutics Holdings, Inc. (CERE)
Company Research
Source: Accesswire
![Accesswire](../../../Content/images/providers/AW.png)
Impact Snapshot
Event Time:
CERE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERE alerts
High impacting Cerevel Therapeutics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
CERE
News
- CEREVEL INVESTOR ALERT: Think $45 Per Share is Too Low for Cerevel (Nasdaq:CERE)? BFA Law Reminds You to Contact the Firm about Ongoing Investigation into the Deal PriceAccesswire
- BFA Law Notice: Cerevel (Nasdaq:CERE) Shareholders are Encouraged to Contact the Firm about Investigation into Whether the $45 Per Share Offer is Enough Accesswire
- Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your LossesAccesswire
- CEREVEL SHAREHOLDER REMINDER: Is $45 Per Share Enough for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Encourages Investors to Contact the FirmGlobeNewswire
- CEREVEL MERGER NEWS: Is $45 Per Share Enough for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Reminds Investors to Contact the Firm About Your Rights Accesswire
CERE
Earnings
- 5/8/24 - Miss
CERE
Sec Filings
- 6/7/24 - Form 4
- 6/7/24 - Form 4
- 6/7/24 - Form 4
- CERE's page on the SEC website